|
1
|
Siegel RL, Miller KD and Jemal A: Cancer
statistics, 2018. CA Cancer J Clin. 68:7–30. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Cheng TY, Cramb SM, Baade PD, Youlden DR,
Nwogu C and Reid ME: The International epidemiology of lung cancer:
Latest trends, disparities, and tumor characteristics. J Thorac
Oncol. 11:1653–1671. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Behera M, Owonikoko TK, Gal AA, Steuer CE,
Kim S, Pillai RN, Khuri FR, Ramalingam SS and Sica GL: Lung
adenocarcinoma staging using the 2011 IASLC/ATS/ERS classification:
A pooled analysis of adenocarcinoma in situ and minimally invasive
adenocarcinoma. Clin Lung Cancer. 17:e57–e64. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Chen Z, Fillmore CM, Hammerman PS, Kim CF
and Wong KK: Non-small-cell lung cancers: A heterogeneous set of
diseases. Nat Rev Cancer. 14:535–546. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Xue K, Li FF, Chen YW, Zhou YH and He J:
Body mass index and the risk of cancer in women compared with men:
A meta-analysis of prospective cohort studies. Eur J Cancer Prev.
26:94–105. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
de Groot PM, Wu CC, Carter BW and Munden
RF: The epidemiology of lung cancer. Transl Luna Cancer Res.
7:220–233. 2018. View Article : Google Scholar
|
|
7
|
Siegel RL, Miller KD and Jemal A: Cancer
statistics, 2017. CA Cancer J Clin. 67:7–30. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Malhotra J, Malvezzi M, Negri E, La
Vecchia C and Boffetta P: Risk factors for lung cancer worldwide.
Eur Respir J. 48:889–902. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Cabili MN, Trapnell C, Goff L, Koziol M,
Tazon-Vega B, Regev A and Rinn JL: Integrative annotation of human
large intergenic noncoding RNAs reveals global properties and
specific subclasses. Genes Dev. 25:1915–1927. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Marchese FP, Raimondi I and Huarte M: The
multidimensional mechanisms of long noncoding RNA function. Genome
Biol. 18:2062017. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Sun Q, Hao Q and Prasanth KV: Nuclear long
noncoding RNAs: Key regulators of gene expression. Trends Genet.
34:142–157. 2018. View Article : Google Scholar :
|
|
12
|
Huarte M: The emerging role of lncRNAs in
cancer. Nat Med. 21:1253–1261. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Lin C and Yang L: Long noncoding RNA in
cancer: Wiring signaling circuitry. Trends Cell Biol. 28:287–301.
2018. View Article : Google Scholar :
|
|
14
|
Ding X, Zhang S, Li X, Feng C, Huang Q,
Wang S, Wang S, Xia W, Yang F, Yin R, et al: Profiling expression
of coding genes, long noncoding RNA, and circular RNA in lung
adenocarcinoma by ribosomal RNA-depleted RNA sequencing. FEBS Open
Bio. 8:544–555. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Tang RX, Chen WJ, He RQ, Zeng JH, Liang L,
Li SK, Ma J, Luo DZ and Chen G: Identification of a RNA-Seq based
prognostic signature with five lncRNAs for lung squamous cell
carcinoma. Oncotarget. 8:50761–50773. 2017.PubMed/NCBI
|
|
16
|
Tian X, Zhang H, Zhang B, Zhao J, Li T and
Zhao Y: Microarray expression profile of long non-coding RNAs in
paclitaxel-resistant human lung adenocarcinoma cells. Oncol Rep.
38:293–300. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Yang J, Lin J, Liu T, Chen T, Pan S, Huang
W and Li S: Analysis of lncRNA expression profiles in non-small
cell lung cancers (NSCLC) and their clinical subtypes. Lung Cancer.
85:110–115. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Peng F, Wang R, Zhang Y, Zhao Z, Zhou W,
Chang Z, Liang H, Zhao W, Qi L, Guo Z and Gu Y: Differential
expression analysis at the individual level reveals a lncRNA
prognostic signature for lung adenocarcinoma. Mol Cancer.
16:982017. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Gibb EA, Warren RL, Wilson GW, Brown SD,
Robertson GA, Morin GB and Holt RA: Activation of an endogenous
retrovirus-associated long non-coding RNA in human adenocarcinoma.
Genome Med. 7:222015. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Kaplan R, Luettich K, Heguy A, Hackett NR,
Harvey BG and Crystal RG: Monoallelic up-regulation of the
imprinted H19 gene in airway epithelium of phenotypically normal
cigarette smokers. Cancer Res. 63:1475–1482. 2003.PubMed/NCBI
|
|
21
|
Chen B, Yu M, Chang Q, Lu Y, Thakur C, Ma
D, Yi Z and Chen F: Mdig de-represses H19 large intergenic
non-coding RNA (lincRNA) by down-regulating H3K9me3 and
heterochromatin. Oncotarget. 4:1427–1437. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Fu Y, Wang W, Li X, Liu Y, Niu Y, Zhang B,
Nie J, Pan B, Wang R and Yang J: lncRNA H19 interacts with
S-adenosylhomocysteine hydrolase to regulate LINE-1 Methylation in
human lung-derived cells exposed to Benzo[a]pyrene. Chemosphere.
207:84–90. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Thai P, Statt S, Chen CH, Liang E,
Campbell C and Wu R: Characterization of a novel long noncoding
RNA, SCAL1, induced by cigarette smoke and elevated in lung cancer
cell lines. Am J Respir Cell Mol Biol. 49:204–211. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Hu L, Tang J, Huang X, Zhang T and Feng X:
Hypoxia exposure upregulates MALAT-1 and regulates the
transcriptional activity of PTB-associated splicing factor in A549
lung adenocarcinoma cells. Oncol Lett. 16:294–300. 2018.PubMed/NCBI
|
|
25
|
Zhou C, Ye L, Jiang C, Bai J, Chi Y and
Zhang H: Long noncoding RNA HOTAIR, a hypoxia-inducible factor-1α
activated driver of malignancy, enhances hypoxic cancer cell
proliferation, migration, and invasion in non-small cell lung
cancer. Tumour Biol. 36:9179–9188. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Guo F, Guo L, Li Y, Zhou Q and Li Z:
MALAT1 is an oncogenic long non-coding RNA associated with tumor
invasion in non-small cell lung cancer regulated by DNA
methylation. Int J Clin Exp Pathol. 8:15903–15910. 2015.
|
|
27
|
Khaitan D, Dinger ME, Mazar J, Crawford J,
Smith MA, Mattick JS and Perera RJ: The melanoma-upregulated long
noncoding RNA SPRY4-IT1 modulates apoptosis and invasion. Cancer
Res. 71:3852–3862. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Sun M, Liu XH, Lu KH, Nie FQ, Xia R, Kong
R, Yang JS, Xu TP, Liu YW, Zou YF, et al: EZH2-mediated epigenetic
suppression of long noncoding RNA SPRY4-IT1 promotes NSCLC cell
proliferation and metastasis by affecting the
epithelial-mesenchymal transition. Cell Death Dis. 5:e12982014.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Wen X, Han XR, Wang YJ, Fan SH, Zhuang J,
Zhang ZF, Shan Q, Li MQ, Hu B, Sun CH, et al: Effects of long
noncoding RNA SPRY4-IT1-mediated EZH2 on the invasion and migration
of lung adenocarcinoma. J Cell Biochem. 119:1827–1840. 2018.
View Article : Google Scholar
|
|
30
|
Zhai N, Xia Y, Yin R, Liu J and Gao F: A
negative regulation loop of long noncoding RNA HOTAIR and p53 in
non-small-cell lung cancer. Onco Targets Ther. 9:5713–5720. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Hung T, Wang Y, Lin MF, Koegel AK, Kotake
Y, Grant GD, Horlings HM, Shah N, Umbricht C, Wang P, et al:
Extensive and coordinated transcription of noncoding RNAs within
cell-cycle promoters. Nat Genet. 43:621–629. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Han L, Zhang EB, Yin DD, Kong R, Xu TP,
Chen WM, Xia R, Shu YQ and De W: Low expression of long noncoding
RNA PANDAR predicts a poor prognosis of non-small cell lung cancer
and affects cell apoptosis by regulating Bcl-2. Cell Death Dis.
6:e16652015. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Barsyte-Lovejoy D, Lau SK, Boutros PC,
Khosravi F, Jurisica I, Andrulis IL, Tsao MS and Penn LZ: The c-Myc
oncogene directly induces the H19 noncoding RNA by allele-specific
binding to potentiate tumorigenesis. Cancer Res. 66:5330–5337.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Lu Y, Zhou X, Xu L, Rong C, Shen C and
Bian W: Long noncoding RNA ANRIL could be transactivated by c-Myc
and promote tumor progression of non-small-cell lung cancer. Onco
Targets Ther. 9:3077–3084. 2016.PubMed/NCBI
|
|
35
|
Huang T, Wang G, Yang L, Peng B, Wen Y,
Ding G and Wang Z: Transcription Factor YY1 modulates lung cancer
progression by activating lncRNA-PVT1. DNA Cell Biol. 36:947–958.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Wan L, Sun M, Liu GJ, Wei CC, Zhang EB,
Kong R, Xu TP, Huang MD and Wang ZX: Long noncoding RNA PVT-1
promotes non-small cell lung cancer cell proliferation through
epigenetically regulating LATS2 expression. Mol Cancer Ther.
15:1082–1094. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Li S, Ma F, Jiang K, Shan H, Shi M and
Chen B: Long non-coding RNA metastasis-associated lung
adenocarcinoma transcript 1 promotes lung adenocarcinoma by
directly interacting with specificity protein 1. Cancer Sci.
109:1346–1356. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Jen J, Tang YA, Lu YH, Lin CC, Lai WW and
Wang YC: Oct4 transcriptionally regulates the expression of long
non-coding RNAs NEAT1 and MALAT1 to promote lung cancer
progression. Mol Cancer. 16:1042017. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Guo F, Jiao F, Song Z, Li S, Liu B, Yang
H, Zhou Q and Li Z: Regulation of MALAT1 expression by TDP43
controls the migration and invasion of non-small cell lung cancer
cells in vitro. Biochem Biophys Res Commun. 465:293–298. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Li S, Mei Z, Hu HB and Zhang X: The lncRNA
MALAT1 contributes to non-small cell lung cancer development via
modulating miR-124/STAT3 axis. J Cell Physiol. 233:6679–6688. 2018.
View Article : Google Scholar
|
|
41
|
Tang Y, Xiao G, Chen Y and Deng Y: lncRNA
MALAT 1 p romotes migration and invasion of non-small-cell lung
cancer by targeting miR-206 and activating Akt/mTOR signaling.
Anticancer Drugs. 29:725–735. 2018.PubMed/NCBI
|
|
42
|
Tripathi V, Ellis JD, Shen Z, Song DY, Pan
Q, Watt AT, Freier SM, Bennett CF, Sharma A, Bubulya PA, et al: The
nuclear-retained noncoding RNA MALAT1 regulates alternative
splicing by modulating SR splicing factor phosphorylation. Mol
Cell. 39:925–938. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Tano K, Onoguchi-Mizutani R, Yeasmin F,
Uchiumi F, Suzuki Y, Yada T and Akimitsu N: Identification of
minimal p53 promoter region regulated by MALAT1 in human lung
adenocarcinoma Cells. Front Genet. 8:2082018. View Article : Google Scholar :
|
|
44
|
Ma J, Wu K, Liu K and Miao R: Effects of
MALAT1 on proliferation and apoptosis of human non-small cell lung
cancer A549 cells in vitro and tumor xenograft growth in vivo by
modulating autophagy. Cancer Biomark. 22:63–72. 2018. View Article : Google Scholar
|
|
45
|
Tsai MC, Manor O, Wan Y, Mosammaparast N,
Wang JK, Lan F, Shi Y, Segal E and Chang HY: Long noncoding RNA as
modular scaffold of histone modification complexes. Science.
329:689–693. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Wang R, Chen X, Xu T, Xia R, Han L, Chen
W, De W and Shu Y: miR-326 regulates cell proliferation and
migration in lung cancer by targeting phox2a and is regulated by
HOTAIR. Am J Cancer Res. 6:173–186. 2016.PubMed/NCBI
|
|
47
|
Feng L, Xie Y, Zhang H and Wu Y: miR-107
targets cyclin-dependent kinase 6 expression, induces cell cycle G1
arrest and inhibits invasion in gastric cancer cells. Med Oncol.
29:856–863. 2012. View Article : Google Scholar
|
|
48
|
Cui J, Mo J, Luo M, Yu Q, Zhou S, Li T,
Zhang Y and Luo W: c-Myc-activated long non-coding RNA H19
downregulates miR-107 and promotes cell cycle progression of
non-small cell lung cancer. Int J Clin Exp Pathol. 8:12400–12409.
2015.
|
|
49
|
Zhang E, Li W, Yin D, De W, Zhu L, Sun S
and Han L: c-Myc-regulated long non-coding RNA H19 indicates a poor
prognosis and affects cell proliferation in non-small-cell lung
cancer. Tumour Biol. 37:4007–4015. 2016. View Article : Google Scholar
|
|
50
|
Huang Z, Lei W, Hu HB, Zhang H and Zhu Y:
H19 promotes non-small-cell lung cancer (NSCLC) development through
STAT3 signaling via sponging miR-17. J Cell Physiol. 233:6768–6776.
2018. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Zhang Q, Li X, Li X, Li X and Chen Z:
lncRNA H19 promotes epithelial-mesenchymal transition (EMT) by
targeting miR-484 in human lung cancer cells. J Cell Biochem.
119:4447–4457. 2018. View Article : Google Scholar
|
|
52
|
Ren J, Fu J, Ma T, Yan B, Gao R, An Z and
Wang D: lncRNA H19-elevated LIN28B promotes lung cancer progression
through sequestering miR-196b. Cell Cycle. 17:1372–1380. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Chen Z, Li JL, Lin S, Cao C, Gimbrone NT,
Yang R, Fu DA, Carper MB, Haura EB, Schabath MB, et al:
cAMP/CREB-regulated LINC00473 marks LKB1-inactivated lung cancer
and mediates tumor growth. J Clin Invest. 126:2267–2279. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
54
|
Li J, Li P, Zhao W, Yang R, Chen S, Bai Y,
Dun S, Chen X, Du Y, Wang Y, et al: Expression of long non-coding
RNA DLX6-AS1 in lung adenocarcinoma. Cancer Cell Int. 15:482015.
View Article : Google Scholar : PubMed/NCBI
|
|
55
|
Naemura M, Murasaki C, Inoue Y, Okamoto H
and Kotake Y: Long noncoding RNA ANRIL regulates proliferation of
non-small cell lung cancer and cervical cancer cells. Anticancer
Res. 35:5377–5382. 2015.PubMed/NCBI
|
|
56
|
Nie FQ, Sun M, Yang JS, Xie M, Xu TP, Xia
R, Liu YW, Liu XH, Zhang EB, Lu KH and Shu YQ: Long noncoding RNA
ANRIL promotes non-small cell lung cancer cell proliferation and
inhibits apoptosis by silencing KLF2 and P21 expression. Mol Cancer
Ther. 14:268–277. 2015. View Article : Google Scholar
|
|
57
|
Hou Z, Zhao W, Zhou J, Shen L, Zhan P, Xu
C, Chang C, Bi H, Zou J, Yao X, et al: A long noncoding RNA Sox2ot
regulates lung cancer cell proliferation and is a prognostic
indicator of poor survival. Int J Biochem Cell Biol. 53:380–388.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
58
|
Flockhart RJ, Webster DE, Qu K,
Mascarenhas N, Kovalski J, Kretz M and Khavari PA: BRAFV600E
remodels the melanocyte transcriptome and induces BANCR to regulate
melanoma cell migration. Genome Res. 22:1006–1014. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
59
|
Jiang W, Zhang D, Xu B, Wu Z, Liu S, Zhang
L, Tian Y, Han X and Tian D: Long non-coding RNA BANCR promotes
proliferation and migration of lung carcinoma via MAPK pathways.
Biomed Pharmacother. 69:90–95. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
60
|
Zhao JM, Cheng W, He XG, Liu YL, Wang FF
and Gao YF: Long non-coding RNA PICART1 suppresses proliferation
and promotes apoptosis in lung cancer cells by inhibiting
JAK2/STAT3 signaling. Neoplasma. 65:779–789. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
61
|
Su W, Feng S, Chen X, Yang X, Mao R, Guo
C, Wang Z, Thomas DG, Lin J, Reddy RM, et al: Silencing of long
noncoding RNA MIR22HG triggers cell Survival/Death signaling via
oncogenes YBX1, MET, and p21 in lung cancer. Cancer Res.
78:3207–3219. 2018.PubMed/NCBI
|
|
62
|
Mondal T, Rasmussen M, Pandey GK, Isaksson
A and Kanduri C: Characterization of the RNA content of chromatin.
Genome Res. 20:899–907. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
63
|
Wei MM, Zhou YC, Wen ZS, Zhou B, Huang YC,
Wang GZ, Zhao XC, Pan HL, Qu LW, Zhang J, et al: Long non-coding
RNA stabilizes the Y-box-binding protein 1 and regulates the
epidermal growth factor receptor to promote lung carcinogenesis.
Oncotarget. 7:59556–59571. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
64
|
Liu M, Sun W, Liu Y and Dong X: The role
of lncRNA MALAT1 in bone metastasis in patients with non-small cell
lung cancer. Oncol Rep. 36:1679–1685. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
65
|
Gutschner T, Hammerle M, Eissmann M, Hsu
J, Kim Y, Hung G, Revenko A, Arun G, Stentrup M, Gross M, et al:
The noncoding RNA MALAT1 is a critical regulator of the metastasis
phenotype of lung cancer cells. Cancer Res. 73:1180–1189. 2013.
View Article : Google Scholar
|
|
66
|
Li J, Wang J, Chen Y, Li S, Jin M, Wang H,
Chen Z and Yu W: lncRNA MALAT1 exerts oncogenic functions in lung
adenocarcinoma by targeting miR-204. Am J Cancer Res. 6:1099–1107.
2016.PubMed/NCBI
|
|
67
|
Jiang C, Yang Y, Yang Y, Guo L, Huang J,
Liu X, Wu C and Zou J: Long noncoding RNA (lncRNA) HOTAIR affects
tumorigenesis and metastasis of non-small cell lung cancer by
upregulating miR-613. Oncol Res. 26:725–734. 2018. View Article : Google Scholar
|
|
68
|
Wang R, Yan B, Li Z, Jiang Y, Mao C, Wang
X and Zhou X: Long non-coding RNA HOX transcript antisense RNA
promotes expression of 14-3-3σ in non-small cell lung cancer. Exp
Ther Med. 14:4503–4508. 2017.PubMed/NCBI
|
|
69
|
Liu XH, Liu ZL, Sun M, Liu J, Wang ZX and
De W: The long non-coding RNA HOTAIR indicates a poor prognosis and
promotes metastasis in non-small cell lung cancer. BMC cancer.
13:4642013. View Article : Google Scholar : PubMed/NCBI
|
|
70
|
Ono H, Motoi N, Nagano H, Miyauchi E,
Ushijima M, Matsuura M, Okumura S, Nishio M, Hirose T, Inase N and
Ishikawa Y: Long noncoding RNA HOTAIR is relevant to cellular
proliferation, invasiveness, and clinical relapse in small-cell
lung cancer. Cancer Med. 3:632–642. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
71
|
Wang R, Shi Y, Chen L, Jiang Y, Mao C, Yan
B, Liu S, Shan B, Tao Y and Wang X: Theratio of FoxA1 to FoxA2 in
lung adenocarcinoma is regulated by lncRNA HOTAIR and chromatin
remodeling factor LSH. Sci Rep. 5:178262015. View Article : Google Scholar
|
|
72
|
Guo D, Wang Y, Ren K and Han X: Knockdown
of lncRNA PVT1 inhibits tumorigenesis in non-small-cell lung cancer
by regulating miR-497 expression. Exp Cell Res. 362:172–179. 2018.
View Article : Google Scholar
|
|
73
|
Chen W, Zhu H, Yin L, Wang T, Wu J, Xu J,
Tao H, Liu J and He X: lncRNA-PVT1 facilitates invasion through
upregulation of MMP9 in nonsmall cell lung cancer cell. DNA Cell
Biol. 36:787–793. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
74
|
Lin L, Gu ZT, Chen WH and Cao KJ:
Increased expression of the long non-coding RNA ANRIL promotes lung
cancer cell metastasis and correlates with poor prognosis. Diagn
Pathol. 10:142015. View Article : Google Scholar : PubMed/NCBI
|
|
75
|
Li Z, Yu X and Shen J: ANRIL: A pivotal
tumor suppressor long non-coding RNA in human cancers. Tumour Biol.
37:5657–5661. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
76
|
Yu T, Zhao Y, Hu Z, Li J, Chu D, Zhang J,
Li Z, Chen B, Zhang X, Pan H, et al: Metalnc9 facilitates lung
cancer metastasis via a PGK1-activated AKT/mTOR pathway. Cancer
Res. 77:5782–5794. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
77
|
Zhang L, Zhou XF, Pan GF and Zhao JP:
Enhanced expression of long non-coding RNA ZXF-1 promoted the
invasion and metastasis in lung adenocarcinoma. Biomed
Pharmacother. 68:401–407. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
78
|
Ge X, Li GY, Jiang L, Jia L, Zhang Z, Li
X, Wang R, Zhou M, Zhou Y, Zeng Z, et al: Long noncoding RNA CAR10
promotes lung adenocarcinoma metastasis via miR-203/30/SNAI axis.
Oncogene. 38:3061–3076. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
79
|
Falzone L, Salomone S and Libra M:
Evolution of cancer pharmacological treatments at the turn of the
third millennium. Front Pharmacol. 9:13002018. View Article : Google Scholar : PubMed/NCBI
|
|
80
|
Sun YW, Xu J, Zhou J and Liu WJ: Targeted
drugs for systemic therapy of lung cancer with brain metastases.
Oncotarget. 9:5459–5472. 2017.
|
|
81
|
Yang CJ, Hung JY, Tsai MJ, Wu KL, Liu TC,
Chou SH, Lee JY, Hsu JS, Huang MS and Chong IW: The salvage therapy
in lung adenocarcinoma initially harbored susceptible EGFR mutation
and acquired resistance occurred to the first-line gefitinib and
second-line cytotoxic chemotherapy. BMC Pharmacol Toxicol.
18:212017. View Article : Google Scholar : PubMed/NCBI
|
|
82
|
Mitsudomi T: Advances in target therapy
for lung cancer. Jpn J Clin Oncol. 40:101–106. 2010. View Article : Google Scholar
|
|
83
|
Konieczna A, Novakova V, Medalova J, Erceg
S and Klabusay M: Thiazolidinediones regulate the level of ABC
transporters expression on lung cancer cells. Klin Onkol.
28:431–438. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
84
|
Gao Y, Li W, Liu X, Gao F and Zhao X:
Reversing effect and mechanism of soluble resistance-related
calcium-binding protein on multidrug resistance in human lung
cancer A549/DDP cells. Mol Med Rep. 11:2118–2124. 2015. View Article : Google Scholar
|
|
85
|
Patel NR, Pattni BS, Abouzeid AH and
Torchilin VP: Nanopreparations to overcome multidrug resistance in
cancer. Adv Drug Deliv Rev. 65:1748–1762. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
86
|
Fang Z, Chen W, Yuan Z, Liu X and Jiang H:
lncRNA-MALAT1 contributes to the cisplatin-resistance of lung
cancer by upregulating MRP1 and MDR1 via STAT3 activation. Biomed
Pharmacother. 101:536–542. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
87
|
Liu MY, Li XQ, Gao TH, Cui Y, Ma N, Zhou Y
and Zhang GJ: Elevated HOTAIR expression associated with cisplatin
resistance in non-small cell lung cancer patients. J Thorac Dis.
8:3314–3322. 2016. View Article : Google Scholar
|
|
88
|
Wang Q, Cheng N, Li X, Pan H, Li C, Ren S,
Su C, Cai W, Zhao C, Zhang L and Zhou C: Correlation of long
non-coding RNA H19 expression with cisplatin-resistance and
clinical outcome in lung adenocarcinoma. Oncotarget. 8:2558–2567.
2017.
|
|
89
|
Liu J, Wan L, Lu K, Sun M, Pan X, Zhang P,
Lu B, Liu G and Wang Z: The long noncoding RNA MEG3 contributes to
cispl-atin resistance of human lung adenocarcinoma. PLoS One.
10:e01145862015. View Article : Google Scholar
|
|
90
|
Yang Y, Li H, Hou S, Hu B, Liu J and Wang
J: The noncoding RNA expression profile and the effect of lncRNA
AK126698 on cisplatin resistance in non-small-cell lung cancer
cell. PLoS One. 8:e653092013. View Article : Google Scholar : PubMed/NCBI
|
|
91
|
Chen W, Zhao W, Zhang L, Wang L, Wang J,
Wan Z, Hong Y and Yu L: MALAT1-miR-101 SOX9 feedback loop modulates
the chemo-resistance of lung cancer cell to DDP via Wnt signaling
pathway. Oncotarget. 8:94317–94329. 2017.PubMed/NCBI
|
|
92
|
Wang H, Wang L, Zhang G, Lu C, Chu H, Yang
R and Zhao G: MALAT1/miR-101 3p/MCL1 axis mediates cisplatin
resistance in lung cancer. Oncotarget. 9:7501–7512. 2017.
|
|
93
|
Liu Z, Sun M, Lu K, Liu J, Zhang M, Wu W,
De W, Wang Z and Wang R: The long noncoding RNA HOTAIR contributes
to cisplatin resistance of human lung adenocarcinoma cells via
downregualtion of p21(WAF1/CIP1) expression. PLoS One.
8:e772932013. View Article : Google Scholar : PubMed/NCBI
|
|
94
|
Rhee I, Bachman KE, Park BH, Jair KW, Yen
RW, Schuebel KE, Cui H, Feinberg AP, Lengauer C, Kinzler KW, et al:
DNMT1 and DNMT3b cooperate to silence genes in human cancer cells.
Nature. 416:552–556. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
95
|
Fang S, Gao H, Tong Y, Yang J, Tang R, Niu
Y, Li M and Guo L: Long noncoding RNA-HOTAIR affects
chemoresistance by regulating HOXA1 methylation in small cell lung
cancer cells. Lab Invest. 96:60–68. 2016. View Article : Google Scholar
|
|
96
|
Kris MG, Natale RB, Herbst RS, Lynch TJ
Jr, Prager D, Belani CP, Schiller JH, Kelly K, Spiridonidis H,
Sandler A, et al: Efficacy of gefitinib, an inhibitor of the
epidermal growth factor receptor tyrosine kinase, in symptomatic
patients with non-small cell lung cancer: A randomized trial. JAMA.
290:2149–2158. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
97
|
Wheler J, Falchook G, Tsimberidou AM, Hong
D, Naing A, Piha-Paul S, Chen SS, Heymach J, Fu S, Stephen B, et
al: Revisiting clinical trials using EGFR inhibitor-based regimens
in patients with advanced non-small cell lung cancer: A
retrospective analysis of an MD Anderson Cancer Center phase I
population. Oncotarget. 4:772–784. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
98
|
Chang YS, Choi CM and Lee JC: Mechanisms
of epidermal growth factor receptor tyrosine kinase inhibitor
resistance and strategies to overcome resistance in lung
adenocarcinoma. Tuberc Respir Dis (Seoul). 79:248–256. 2016.
View Article : Google Scholar
|
|
99
|
Cheng N, Li X, Zhao C, Ren S, Chen X, Cai
W, Zhao M, Zhang Y, Li J, Wang Q and Zhou C: Microarray expression
profile of long non-coding RNAs in EGFR-TKIs resistance of human
non-small cell lung cancer. Oncol Rep. 33:833–839. 2015. View Article : Google Scholar
|
|
100
|
Liu Y, Jiang H, Zhou H, Ying X, Wang Z,
Yang Y, Xu W, He X and Li Y: Lentivirus-mediated silencing of
HOTAIR lncRNA restores gefitinib sensitivity by activating
Bax/caspase-3 and suppressing TGF-α/EGFR signaling in lung
adenocarcinoma. Oncol Lett. 15:2829–2838. 2018.PubMed/NCBI
|
|
101
|
Cheng N, Cai W, Ren S, Li X, Wang Q, Pan
H, Zhao M, Li J, Zhang Y, Zhao C, et al: Long non-coding RNA UCA1
induces non-T790M acquired resistance to EGFR-TKIs by activating
the AKT/mTOR pathway in EGFR-mutant non-small cell lung cancer.
Oncotarget. 6:23582–23593. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
102
|
Dong S, Qu X, Li W, Zhong X, Li P, Yang S,
Chen X, Shao M and Zhang L: The long non-coding RNA, GAS5, enhances
gefitinib-induced cell death in innate EGFR tyrosine kinase
inhibitor-resistant lung adenocarcinoma cells with wide-type EGFR
via downregulation of the IGF-1R expression. J Hematol Oncol.
8:432015. View Article : Google Scholar : PubMed/NCBI
|
|
103
|
Yang Y, Jiang C, Yang Y, Guo L, Huang J,
Liu X, Wu C and Zou J: Silencing of lncRNA-HOTAIR decreases drug
resistance of Non-small cell lung cancer cells by inactivating
autophagy via suppressing the phosphorylation of ULK1. Biochem
Biophys Res Commun. 497:1003–1010. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
104
|
Chen J, Shen Z, Zheng Y, Wang S and Mao W:
Radiotherapy induced Lewis lung cancer cell apoptosis via
inactivating β-catenin mediated by upregulated HOTAIR. Int J Clin
Exp Pathol. 8:7878–7886. 2015.
|
|
105
|
Wu D, Li Y, Zhang H and Hu X: Knockdown of
lncrna PVT1 enhances radiosensitivity in Non-small cell lung cancer
by sponging Mir-195. Cell Physiol Biochem. 42:2453–2466. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
106
|
Chen JX, Chen M, Zheng YD, Wang SY and
Shen ZP: Up-regulation of BRAF activated non-coding RNA is
associated with radiation therapy for lung cancer. Biomed
Pharmacother. 71:79–83. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
107
|
Loewen G, Jayawickramarajah J, Zhuo Y and
Shan B: Functions of lncRNA HOTAIR in lung cancer. J Hematol Oncol.
7:902014. View Article : Google Scholar : PubMed/NCBI
|
|
108
|
Nakagawa T, Endo H, Yokoyama M, Abe J,
Tamai K, Tanaka N, Sato I, Takahashi S, Kondo T and Satoh K: Large
noncoding RNA HOTAIR enhances aggressive biological behavior and is
associated with short disease-free survival in human non-small cell
lung cancer. Biochem Biophys Res Commun. 436:319–324. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
109
|
Li N, Wang Y, Liu X, Luo P, Jing W, Zhu M
and Tu J: Identification of Circulating long noncoding RNA HOTAIR
as a novel biomarker for diagnosis and monitoring of Non-small cell
lung cancer. Technol Cancer Res Treat. Jan 1–2017. View Article : Google Scholar : Epub ahead of
print.
|
|
110
|
Wu X, Ruan L, Yang Y and Mei Q:
Identification of crucial regulatory relationships between long
non-coding RNAs and protein-coding genes in lung squamous cell
carcinoma. Mol Cell Probes. 30:146–152. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
111
|
Cui D, Yu CH, Liu M, Xia QQ, Zhang YF and
Jiang WL: Long non-coding RNA PVT1 as a novel biomarker for
diagnosis and prognosis of non-small cell lung cancer. Tumour Biol.
37:4127–4134. 2016. View Article : Google Scholar
|
|
112
|
Yang YR, Zang SZ, Zhong CL, Li YX, Zhao SS
and Feng XJ: Increased expression of the lncRNA PVT1 promotes
tumori-genesis in non-small cell lung cancer. Int J Clin Exp
Pathol. 7:6929–6935. 2014.
|
|
113
|
Hu X, Bao J, Wang Z, Zhang Z, Gu P, Tao F,
Cui D and Jiang W: The plasma lncRNA acting as fingerprint in
non-small-cell lung cancer. Tumour Biol. 37:3497–3504. 2016.
View Article : Google Scholar
|
|
114
|
Xie Y, Zhang Y, Du L, Jiang X, Yan S, Duan
W, Li J, Zhan Y, Wang L, Zhang S, et al: Circulating long noncoding
RNA act as potential novel biomarkers for diagnosis and prognosis
of non-small cell lung cancer. Mol Oncol. 12:648–658. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
115
|
Schmidt LH, Spieker T, Koschmieder S,
Schaffers S, Humberg J, Jungen D, Bulk E, Hascher A, Wittmer D,
Marra A, et al: The long noncoding MALAT-1 RNA indicates a poor
prognosis in non-small cell lung cancer and induces migration and
tumor growth. J Thorac Oncol. 6:1984–1992. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
116
|
Ji P, Diederichs S, Wang W, Böing S,
Metzger R, Schneider PM, Tidow N, Brandt B, Buerger H, Bulk E, et
al: MALAT-1, a novel noncoding RNA, and thymosin beta4 predict
metastasis and survival in early-stage non-small cell lung cancer.
Oncogene. 22:8031–8041. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
117
|
Lin L, Li H, Zhu Y, He S and Ge H:
Expression of metastasis-associated lung adenocarcinoma transcript
1 long non-coding RNA in vitro and in patients with non-small cell
lung cancer. Oncol Lett. 15:9443–9449. 2018.PubMed/NCBI
|
|
118
|
Tian X and Xu G: Clinical value of lncRNA
MALAT1 as a prognostic marker in human cancer: Systematic review
and meta-analysis. BMJ Open. 5:e0086532015. View Article : Google Scholar : PubMed/NCBI
|
|
119
|
Weber DG, Johnen G, Casjens S, Bryk O,
Pesch B, Jöckel KH, Kollmeier J and Brüning T: Evaluation of long
noncoding RNA MALAT1 as a candidate blood-based biomarker for the
diagnosis of non-small cell lung cancer. BMC Res Notes. 6:5182013.
View Article : Google Scholar : PubMed/NCBI
|
|
120
|
Zhang R, Xia Y, Wang Z, Zheng J, Chen Y,
Li X, Wang Y and Ming H: Serum long non coding RNA MALAT-1
protected by exosomes is up-regulated and promotes cell
proliferation and migration in non-small cell lung cancer. Biochem
Biophys Res Commun. 490:406–414. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
121
|
Sun M, Liu XH, Wang KM, Nie FQ, Kong R,
Yang JS, Xia R, Xu TP, Jin FY, Liu ZJ, et al: Downregulation of
BRAF activated non-coding RNA is associated with poor prognosis for
non-small cell lung cancer and promotes metastasis by affecting
epithelial-mesenchymal transition. Mol Cancer. 13:682014.
View Article : Google Scholar : PubMed/NCBI
|
|
122
|
Liang W, Lv T, Shi X, Liu H, Zhu Q, Zeng
J, Yang W, Yin J and Song Y: Circulating long noncoding RNA GAS5 is
a novel biomarker for the diagnosis of nonsmall cell lung cancer.
Medicine (Baltimore). 95:e46082016. View Article : Google Scholar
|
|
123
|
Tantai J, Hu D, Yang Y and Geng J:
Combined identification of long non-coding RNA XIST and HIF1A-AS1
in serum as an effective screening for non-small cell lung cancer.
Int J Clin Exp Pathol. 8:7887–7895. 2015.PubMed/NCBI
|
